Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Section 4: Oscillations in β-Cells

Role of Oscillations in Membrane Potential, Cytoplasmic Ca2+, and Metabolism for Plasma Insulin Oscillations

  1. Peter Bergsten
  1. From the Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
    Diabetes 2002 Feb; 51(suppl 1): S171-S176. https://doi.org/10.2337/diabetes.51.2007.S171
    PreviousNext
    • Article
    • Figures & Tables
    • Info & Metrics
    • PDF
    Loading

    Abstract

    A model for the relationship between ionic and metabolic oscillations and plasma insulin oscillations is presented. It is argued that the pancreatic β-cell in vivo displays two intrinsic frequencies that are important for the regulation of plasma insulin oscillations. The rapid oscillatory activity (2–7 oscillations [osc] per minute), which is evident in both ionic and metabolic events, causes the required elevation in cytoplasmic Ca2+ concentration ([Ca2+]i) for the exocytosis of insulin granules. This activity is important for regulation of the amplitude of plasma insulin oscillations. The frequency of the rapid oscillatory ionic activities is regulated by glucose and allows the β-cell to respond in an analogous way, with gradual changes in [Ca2+]i and insulin release in response to the alterations in glucose concentration. The slower oscillatory activity (0.2–0.4 osc/min), which is evident in the metabolism of the β-cell, has a frequency corresponding to the frequency observed in plasma insulin oscillations. The frequency is not affected by changes in the glucose concentration. This activity is suggested to generate energy in a pulsatile fashion, which sets the frequency of the plasma insulin oscillations. It is proposed that the slow oscillations in [Ca2+]i observed in vitro are a manifestation of the metabolic oscillations and do not represent an in vivo phenomenon.

    Regular variations in the blood concentration of insulin with typical durations of several minutes are present in humans (1,2). The frequency of the insulin pulses is important for the action of the hormone. Significantly less insulin is required when administered in a pulsatile fashion rather than as a bolus injection (3–7), which may result in different expression of the insulin receptor on target tissue (8). Indeed, a contributing cause to the glucose intolerance in type 2 diabetes may be related to the loss of the regular accentuated plasma insulin oscillations (9,10), which could aggravate insulin resistance by receptor downregulation.

    The oscillatory behavior seems to be intrinsic of the β-cell. Oscillations in the β-cell membrane potential, cytoplasmic Ca2+ concentration ([Ca2+]i), and metabolism, with similar frequencies as the plasma insulin oscillations, have been described and suggested to be responsible for the pulsatile release of insulin (11–18,19). However, observations and conclusions made from experiments with isolated β-cells or islets do not necessarily translate into the in vivo situation. When evaluating the possible effects of oscillatory membrane potential, [Ca2+]i, and metabolism on plasma insulin oscillations, oscillatory activities with different frequencies have to be considered. In this context, the oscillatory activity with a frequency of 2–7 oscillations (osc) per minute and that with a frequency of 0.2–0.4 osc/min will be discussed. Experimental observations of these rapid and slow islet oscillatory activities in vivo and in vitro are reviewed, together with an in vivo model of the β-cell, where the role of the oscillatory activities in membrane potential, [Ca2+]i, and metabolism for the generation of plasma insulin oscillations are presented and discussed.

    IN VITRO OSCILLATIONS OF ISLET MEMBRANE POTENTIAL AND [Ca2+]i

    Rapid oscillations in membrane potential and [Ca2+]i (2–7 osc/min) have been observed and characterized in the isolated islet (14,15,20–29). The membrane potential measurements consist of “slow waves,” which are periods of depolarization when accumulations of action potentials (“bursts”) promote influx of Ca2+, interspersed with periods of hyperpolarization, when no Ca2+ influx is present. These slow waves give rise to the rapid oscillations in [Ca2+]i. The glucose concentration affects both the duration of the bursts and the time relationship between periods of depolarization and hyperpolarization, i.e., the frequency of the slow waves (30).

    Slow oscillations (0.2–0.4 osc/min) in [Ca2+]i (15,23,26–28,31) and in membrane potential activity (32–34) have been recorded and characterized in the isolated islet. The frequency of these oscillations is not affected by the glucose concentration (23,27). The slow oscillations of [Ca2+]i are primarily observed in cultured islets. As the culture period is extended, the rapid [Ca2+]i oscillations disappear in favor of the slow ones, which also disappear after prolonged culture (31). The glucose concentration during culture is also decisive for the [Ca2+]i oscillatory pattern (26). Although a low-culture glucose concentration makes the islet incapable of responding to glucose-induced [Ca2+]i oscillations, an intermediate-culture glucose concentration is compatible with subsequent glucose-induced rapid and slow [Ca2+]i oscillations. The dependence of the [Ca2+]i oscillatory pattern on culture period and glucose concentration is related to islet cAMP content (35–38). Indeed, when the content of cAMP was increased in the isolated islet, the regular electrical activity was promoted (39) and the slow [Ca2+]i oscillations were replaced by the rapid oscillatory pattern (15,29). Freshly isolated islets predominantly exhibited the rapid [Ca2+]i oscillations (23,24,28). Also, membrane potential recordings from freshly microdissected islets showed the rapid oscillatory pattern of β-cell electrical activity (20,21,23–25).

    IN VIVO OSCILLATIONS OF ISLET MEMBRANE POTENTIAL AND [Ca2+]i

    Oscillations in β-cell membrane potential and islet [Ca2+]i have been monitored in vivo (40–42). The membrane potential recordings showed glucose-dependent high-frequency oscillations (Fig. 1). These rapid oscillations were also observed in the [Ca2+]i measurements (Fig. 2). No evidence of low-frequency oscillatory activity has been found so far using membrane potential or [Ca2+]i recording techniques.

    IN VITRO OSCILLATIONS OF ISLET METABOLISM

    Isolated islets also showed oscillations in metabolism with both the high- and low-frequency component. The low-frequency oscillations were observed in measurements of oxygen tension (pO2) in individual islets (18,19,43) and groups of islets (13), lactate production in groups of islets (44), and ATP/ADP ratio in suspensions of mouse β-cells (17). The high-frequency oscillations were observed in pO2 in individual islets and were synchronous with the rapid changes in [Ca2+]i (18,43). Activation of the mitochondrial Ca2+-dependent dehydrogenases (45,46) may well serve as linkage between the two oscillatory phenomena, irrespective of whether oscillations in [Ca2+]i initiate changes in pO2 or vice versa. The slow oscillations in pO2 were ascribed to oscillations in glycolysis (13), electrical activity (11), and Ca2+ entry through the voltage-independent Ca2+ channels (47). In favor of a glycolytic oscillator, pulses of insulin release have been found at low glucose concentrations when [Ca2+]i was low and stable, but pO2 oscillated in synchronous measurements of insulin release and [Ca2+]i (48) and insulin release and pO2 (19). Also, when using the activity of the ATP-sensitive K+ channel as an indicator of the ATP/ADP ratio, oscillations in the channel activity were recorded in β-cells with a stable and low [Ca2+]i (49).

    IN VIVO OSCILLATIONS OF ISLET METABOLISM

    When modified Clark-like electrodes were inserted into islets of the living rat, rapid and slow oscillations in islet pO2 were demonstrated (Fig. 3) (P.B., J. Westerlund, P. Liss, P.O. Carlsson, unpublished data).

    MODEL OF IN VIVO OSCILLATORY MEMBRANE POTENTIAL, [Ca2+]i, pO2, AND INSULIN RELEASE

    The proposed relationship between oscillations in membrane potential, [Ca2+]i, and metabolism (pO2) is outlined in Fig. 4, together with how the oscillatory activities relate to the pulsatile release of insulin from the pancreatic β-cell in vivo. It is suggested that the slow oscillatory activity is a metabolic (pO2) manifestation, which gives rise to the slow oscillations in insulin release. Furthermore, it is suggested that the rapid oscillatory activity can be seen in membrane potential, [Ca2+]i, pO2, and insulin, where glucose-dependent membrane potential changes cause oscillations in [Ca2+]i via periodic entry of Ca2+. These rapid [Ca2+]i oscillations are linked to changes in metabolism (pO2) and initiate the rapid secretory events. At normoglycemia (Fig. 4A), one slow oscillation in pO2 and insulin is shown (approximate duration 5 min) with superimposed rapid oscillations. At hyperglycemia (Fig. 4B), glucose-induced amplification of the amplitude of the slow oscillatory activities in pO2 and insulin is observed together with a lengthening of the periods of action potential (membrane potential).

    DISCUSSION OF THE MODEL

    Role of rapid oscillatory activity in vivo.

    The rapid oscillatory ionic activities set the [Ca2+]i of the β-cell. The rapid oscillatory ionic and metabolic events are instrumental for the amplitude regulation of plasma insulin oscillations in setting the [Ca2+]i, which plays a key role in exocytosis of insulin (50). This is achieved in a glucose-dependent manner by changing the duration of the bursts and frequency of the slow waves, which determine rapid [Ca2+]i events. The alterations in duration of the bursts and the frequency of the slow waves do not depend on a certain glucose concentration but seem to be continuously mirroring changes in the ambient glucose concentration in vivo (40). In isolated islets, the relationship between duration of the bursts and glucose concentration is strikingly similar to the relationship between insulin release and glucose concentration (30). It is reasonable to assume that a similar relationship exists between the rapid oscillatory ionic activity and insulin release in vivo (40–42), which has also been suggested (42). Such a relationship implies a situation in which the secretory response of the β-cell can vary continuously, i.e., is analogous, in a glucose-dependent manner. Another model of explaining the graded response to variations in the glucose concentration is the digital model, where the existence of different populations of β-cells, which become actively secreting, are “recruited” at different glucose concentrations (51). The existence of such subpopulations has been demonstrated in dispersed β-cells (52). As a consequence, the concept of the β-cell as the fuel sensor (53) would require a set of β-cells with varying numbers of β-cells with different glucose sensitivities covering the physiological range. With the analogous model, this set of β-cells is not required because the fuel-sensing capacity would reside in each β-cell. The observations that glucose-induced changes in insulin release are not accompanied by changes in [Ca2+]i oscillatory pattern in the isolated islet (27) and that β-cells in the same islet and islets in the same pancreas respond with similar alterations in the oscillatory activity to changes in the blood glucose concentration (42,54) seem to favor the analogous model. In this context, it should be noted that the rapid oscillatory changes are synchronized between β-cells in the islet but not between islets in the pancreas (42,54).

    The interrelationship between the rapid oscillatory activity in metabolism and ionic movements is complex; both ionic changes have been proposed to drive metabolism by activating dehydrogenases (55,56) and oscillatory metabolic changes to precede the ionic movements (17,57). Irrespective of causality, it can be assumed that the rapid regular ionic and metabolic events have their secretory counterpart also in vivo, as has been demonstrated in the isolated islet (14,25,26,58–61). However, it is not clear if these rapid secretory events are detectable by plasma insulin measurements because there is no synchronization of the oscillations in electrical activity of different islets from the same pancreas in vivo (54).

    Role of the slow oscillatory activity in vivo.

    The slow oscillatory pattern, which is suggested to be a metabolic phenomenon in vivo, closely follows that of secretion (13,19) and seems to be responsible for the plasma insulin oscillations. Indeed, the recently observed slow in vivo oscillations in islet pO2 were synchronous with plasma insulin oscillations in the portal vein (P.B., J. Westerlund, P. Liss, P.O. Carlsson, unpublished data). The frequency of these slow metabolic and plasma insulin oscillations corresponds to that of the plasma insulin oscillations found in humans (2).

    The metabolic oscillations have been proposed to depend on the autocatalytic role of phosphofructokinase to initiate glycolytic oscillations (16). This mechanism has, however, not been demonstrated in the β-cell, and the way in which the regular variations in metabolism are achieved in the β-cell is still elusive. Nevertheless, variations in the ATP/ADP ratio have been observed (17) and could explain the slow insulin oscillations because the exocytotic process, apart from requiring elevation of [Ca2+]i, is also ATP-dependent (62). In contrast to the rapid oscillatory activity, changes in the glucose concentration do not alter the frequency of the slow oscillations (15,23,27,63).

    For regular plasma insulin variations to occur, coordination of the secretory activities of the islets of Langerhans in the pancreas is required (9,64–67). Insulin release from the isolated perfused pancreas is pulsatile (68), which implies that factors within the pancreas are capable of coordinating the secretory activities. Some potential factors with such a coordinating role were recently reviewed (67). In this context, the slow metabolic oscillations may also contribute to the synchronization because oscillations in pO2 of the exocrine pancreas have a similar frequency to those of the endocrine pancreas (P.B., J. Westerlund, P. Liss, P.O. Carlsson, unpublished data).

    Are slow [Ca2+]i oscillations absent in vivo?

    It could be argued that the reported absence of slow [Ca2+]i oscillations in vivo is the result of technical limitations, which made the duration of the recordings too short to observe the oscillations (42). In such case, it is just a matter of time and technical development before we will also be able to see them in vivo. However, there are reasons to believe that the rapid [Ca2+]i oscillations alone represent the in vivo [Ca2+]i manifestations.

    The in vitro results with progression from rapid oscillations in [Ca2+]i in freshly isolated islets (23,24,28) and islets with enhanced cAMP content (15,29) via islets showing a mixture of rapid and slow oscillations in [Ca2+]i (15,23,26,27,29,31) to islets with only slow oscillations in [Ca2+]i after extended culture (31) are intriguing. The recordings of membrane potential also support the idea of the rapid oscillatory activity as the sole ionic oscillatory pattern in vivo. Freshly microdissected islets show an oscillatory pattern of β-cell electrical activity (20–22) almost identical to the recordings observed in vivo (40,41).

    What are slow oscillations in membrane potential and [Ca2+]i?

    The slow oscillations in [Ca2+]i have been explained by regular variations in the ATP/ADP ratio, which control the conductance of ATP-dependent K+ channels leading to depolarization and periodic influx of Ca2+ (69). The frequency of these slow [Ca2+]i oscillations coincides with the frequency of the slow metabolic oscillations present both in vivo and in vitro. If the proposed model of oscillatory activities of the β-cell is correct, the slow oscillations in [Ca2+]i as well as in membrane potential are manifestations of the slow metabolic oscillations.

    Why are rapid but not slow [Ca2+]i oscillations present in vivo?

    The rapid oscillatory activities fine-tune the [Ca2+]i to the ambient glucose concentration by modulating both the duration of the bursts and the frequency of the slow waves. This arrangement allows the β-cell to continuously monitor and respond to changes in the glucose concentration. In contrast, the slow [Ca2+]i oscillations are not elicited until a certain threshold concentration of the glucose is reached (51). Although it is argued that this threshold concentration may vary between β-cells when explaining glucose-induced changes in insulin release (52), in most islets, 11 mmol/l glucose or more is needed to elicit these slow [Ca2+]i oscillations (15,23,26–28,31). The need of the islet to reach such a high threshold concentration before it responds with [Ca2+]i oscillations is clearly not satisfactory in terms of requirements for blood glucose handling, and one wonders how such islets would function in vivo.

    CONCLUSIONS

    The pancreatic β-cell displays a rapid and a slow oscillatory activity. The rapid ionic activity increases [Ca2+]i, which is critical for the amplitude regulation of plasma insulin oscillations. The rapid oscillations are regulated by glucose and allow the β-cell to respond with gradual changes in [Ca2+]i in response to the alterations in the ambient glucose concentration. The slow metabolic activity has a frequency corresponding to the frequency observed in the plasma insulin oscillations. The slow metabolic oscillations generate energy in a pulsatile fashion, which sets the frequency of the plasma insulin oscillations.

    FIG. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Patterns of electrical activity for different glycemic levels. Specimen intracellular records of the electrical activity recorded in vivo from islets of Langerhans of different animals are shown (A–C). The blood glucose concentration measured during the electrical recordings is indicated in each trace. Reproduced with permission from Sanchez-Andres et al. (40).

    FIG. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Spatial analysis of the in vivo calcium oscillations in an islet of Langerhans. The zones depicted in the diagram correspond to the zone of the islet with sufficient fluorescence at 340 nm. Reproduced with permission from Fernandez and Valdeolmillos (42).

    FIG. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    In vivo recording of islet pO2 from an anesthetized rat. Oxygen tension was measured with a modified Clark-like electrode. The blood glucose concentration was 6.4 mmol/l during the recording (P.B., J. Westerlund, P. Liss, P.O. Carlsson, unpublished data).

    FIG. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Model of in vivo oscillatory membrane potential (MP), [Ca2+]i, pO2, and insulin (INS) release. The relationship between rapid and slow oscillatory activities at normoglycemia (A) and hyperglycemia (B) is shown.

    Acknowledgments

    This study was supported by grants from the Swedish Medical Research Council (72X-14019), Swedish Diabetes Association, Novo Nordisk Foundation, Family Ernfors Foundation, Magnus Bergvalls Foundation, Marcus and Amalia Wallenberg Foundation, Swedish Foundation for Strategic Research, and Göran Gustafsson Foundation.

    The author would like to thank Johanna Westerlund, Jian-Man Lin, and Henrik Ortsäter for valuable discussions during the preparation of the manuscript and Henrik Orsäter for assistance with illustrations.

    Footnotes

    • Address correspondence and reprint requests to peter.bergsten{at}medcellbiol.uu.se

      Accepted for publication 25 June 2001.

      [Ca2+]i, cytoplasmic Ca2+concentration; osc, oscillations.

      The symposium and the publication of this article have been made possible by an unrestricted educational grant from Servier, Paris.

    REFERENCES

    1. ↵
      Lang DA, Matthews DR, Peto J, Turner RC: Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings. N Engl J Med 301:1023–1027, 1979
      OpenUrlCrossRefPubMedWeb of Science
    2. ↵
      Porksen N, Nyholm B, Veldhuis JD, Butler PC, Schmitz O: In humans at least 75% of insulin secretion arises from punctuated insulin secretory bursts. Am J Physiol 273:E908–E914, 1997
      OpenUrlAbstract/FREE Full Text
    3. ↵
      Matthews DR, Lang DA, Burnett MA, Turner RC: Control of pulsatile insulin secretion in man. Diabetologia 24:231–237, 1983
      OpenUrlCrossRefPubMedWeb of Science
    4. Paolisso G, Sgambato S, Passariello N, Scheen A, D’Onofrio F, Lefebvre PJ: Greater efficacy of pulsatile insulin in type I diabetics critically depends on plasma glucagon levels. Diabetes 36:566–570, 1987
      OpenUrlAbstract/FREE Full Text
    5. Paolisso G, Sgambato S, Torella R, Varricchio M, Scheen A, D’Onofrio F, Lefebvre PJ: Pulsatile insulin delivery is more efficient than continuous infusion in modulating islet cell function in normal subjects and patients with type 1 diabetes. J Clin Endocrinol Metab 66:1220–1226, 1988
      OpenUrlCrossRefPubMedWeb of Science
    6. Koopmans SJ, Sips HC, Krans HM, Radder JK: Pulsatile intravenous insulin replacement in streptozotocin diabetic rats is more efficient than continuous delivery: effects on glycaemic control, insulin-mediated glucose metabolism and lipolysis. Diabetologia 39:391–400, 1996
      OpenUrlCrossRefPubMed
    7. ↵
      Bratusch-Marrain PR, Komjati M, Waldhausl WK: Efficacy of pulsatile versus continuous insulin administration on hepatic glucose production and glucose utilization in type I diabetic humans. Diabetes 35:922–926, 1986
      OpenUrlAbstract/FREE Full Text
    8. ↵
      Goodner CJ, Sweet IR, Harrison HC Jr: Rapid reduction and return of surface insulin receptors after exposure to brief pulses of insulin in perifused rat hepatocytes. Diabetes 37:1316–1323, 1988
      OpenUrlAbstract/FREE Full Text
    9. ↵
      Lang DA, Matthews DR, Burnett M, Turner RC: Brief, irregular oscillations of basal plasma insulin and glucose concentrations in diabetic man. Diabetes 30:435–439, 1981
      OpenUrlAbstract/FREE Full Text
    10. ↵
      Schmitz O, Juhl CB, Hollingdal M, Veldhuis JD, Porksen N, Pincus SM: Irregular circulating insulin concentrations in type 2 diabetes mellitus: an inverse relationship between circulating free fatty acid and the disorderliness of an insulin time series in diabetic and healthy individuals. Metabolism 50:41–46, 2001
      OpenUrlCrossRefPubMed
    11. ↵
      Rosario LM, Atwater I, Scott AM: Pulsatile insulin release and electrical activity from single ob/ob mouse islets of Langerhans. Adv Exp Med Biol 211:413–425, 1986
      OpenUrlCrossRefPubMed
    12. Grapengiesser E, Gylfe E, Hellman B: Glucose-induced oscillations of cytoplasmic Ca2+ in the pancreatic beta-cell. Biochem Biophys Res Commun 151:1299–1304, 1988
      OpenUrlCrossRefPubMedWeb of Science
    13. ↵
      Longo EA, Tornheim K, Deeney JT, Varnum BA, Tillotson D, Prentki M, Corkey BE: Oscillations in cytosolic free Ca2+, oxygen consumption, and insulin secretion in glucose-stimulated rat pancreatic islets. J Biol Chem 266:9314–9319, 1991
      OpenUrlAbstract/FREE Full Text
    14. ↵
      Gilon P, Shepherd RM, Henquin JC: Oscillations of secretion driven by oscillations of cytoplasmic Ca2+ as evidenced in single pancreatic islets. J Biol Chem 268:22265–22268, 1993
      OpenUrlAbstract/FREE Full Text
    15. ↵
      Bergsten P, Grapengiesser E, Gylfe E, Tengholm A, Hellman B: Synchronous oscillations of cytoplasmic Ca2+ and insulin release in glucose-stimulated pancreatic islets. J Biol Chem 269:8749–8753, 1994
      OpenUrlAbstract/FREE Full Text
    16. ↵
      Tornheim K: Are metabolic oscillations responsible for normal oscillatory insulin secretion? Diabetes 46:1375–1380, 1997
      OpenUrlAbstract/FREE Full Text
    17. ↵
      Nilsson T, Schultz V, Berggren PO, Corkey BE, Tornheim K: Temporal patterns of changes in ATP/ADP ratio, glucose 6-phosphate and cytoplasmic free Ca2+ in glucose-stimulated pancreatic beta-cells. Biochem J 314:91–94, 1996
    18. ↵
      Jung SK, Kauri LM, Qian WJ, Kennedy RT: Correlated oscillations in glucose consumption, oxygen consumption, and intracellular free Ca2+ in single islets of Langerhans. J Biol Chem 275:6642–6650, 2000
      OpenUrlAbstract/FREE Full Text
    19. ↵
      Ortsäter H, Liss P, Lund PE, Åkerman KEO, Bergsten P: Oscillations in oxygen tension and insulin release of individual pancreatic ob/ob mouse islets. Diabetologia 43:1313–1318, 2000
      OpenUrlCrossRefPubMedWeb of Science
    20. ↵
      Dean PM, Matthews EK: Electrical activity in pancreatic islet cells. Nature 219:389–390, 1968
      OpenUrlCrossRefPubMed
    21. ↵
      Dean PM, Matthews EK: Glucose-induced electrical activity in pancreatic islet cells. J Physiol 210:255–264, 1970
      OpenUrlPubMedWeb of Science
    22. ↵
      Henquin JC: d-Glucose inhibits potassium efflux from pancreatic islet cells. Nature 271:271–273, 1978
      OpenUrlCrossRefPubMed
    23. ↵
      Valdeolmillos M, Santos RM, Contreras D, Soria B, Rosario LM: Glucose-induced oscillations of intracellular Ca2+ concentration resembling bursting electrical activity in single mouse islets of Langerhans. FEBS Lett 259:19–23, 1989
      OpenUrlCrossRefPubMedWeb of Science
    24. ↵
      Santos RM, Rosario LM, Nadal A, Garcia-Sancho J, Soria B, Valdeolmillos M: Widespread synchronous [Ca2+]i oscillations due to bursting electrical activity in single pancreatic islets. Pflugers Arch 418:417–422, 1991
      OpenUrlCrossRefPubMedWeb of Science
    25. ↵
      Gilon P, Henquin JC: Influence of membrane potential changes on cytoplasmic Ca2+ concentration in an electrically excitable cell, the insulin-secreting pancreatic B-cell. J Biol Chem 267:20713–20720, 1992
      OpenUrlAbstract/FREE Full Text
    26. ↵
      Bergsten P: Slow and fast oscillations of cytoplasmic Ca2+ in pancreatic islets correspond to pulsatile insulin release. Am J Physiol 268:E282–E287, 1995
      OpenUrlAbstract/FREE Full Text
    27. ↵
      Bergsten P: Glucose-induced pulsatile insulin release from single islets at stable and oscillatory cytoplasmic Ca2+. Am J Physiol 274:E796–E800, 1998
      OpenUrlAbstract/FREE Full Text
    28. ↵
      Martin F, Sanchez-Andres JV, Soria B: Slow [Ca2+]i oscillations induced by ketoisocaproate in single mouse pancreatic islets. Diabetes 44:300–305, 1995
      OpenUrlAbstract/FREE Full Text
    29. ↵
      Liu YJ, Tengholm A, Grapengiesser E, Hellman B, Gylfe E: Origin of slow and fast oscillations of Ca2+ in mouse pancreatic islets. J Physiol (Lond) 508:471–481, 1998
      OpenUrlCrossRefPubMedWeb of Science
    30. ↵
      Meissner HP, Schmelz H: Membrane potential of beta-cells in pancreatic islets. Pflugers Arch 351:195–206, 1974
      OpenUrlCrossRefPubMedWeb of Science
    31. ↵
      Gilon P, Jonas JC, Henquin JC: Culture duration and conditions affect the oscillations of cytoplasmic calcium concentration induced by glucose in mouse pancreatic islets. Diabetologia 37:1007–1014, 1994
      OpenUrlPubMedWeb of Science
    32. ↵
      Cook DL: Isolated islets of Langerhans have slow oscillations of electrical activity. Metabolism 32:681–685, 1983
      OpenUrlCrossRefPubMedWeb of Science
    33. Lebrun P, Atwater I: Chaotic and irregular bursting electrical activity in mouse pancreatic B-cells. Biophys J 48:529–531, 1985
      OpenUrlCrossRefPubMed
    34. ↵
      Henquin JC, Meissner HP, Schmeer W: Cyclic variations of glucose-induced electrical activity in pancreatic B cells. Pflugers Arch 393:322–327, 1982
      OpenUrlCrossRefPubMedWeb of Science
    35. ↵
      Rabinovitch A, Grill V, Renold AE, Cerasi E: Insulin release and cyclic AMP accumulation in response to glucose in pancreatic islets of fed and starved rats. J Clin Invest 58:1209–1216, 1976
    36. Grill V, Cerasi E: Effect of hexoses and mannoheptulose on cyclic AMP accumulation and insulin secretion in rat pancreatic islets. Biochim Biophys Acta 437:36–50, 1976
      OpenUrlPubMed
    37. Schuit FC, Pipeleers DG: Regulation of adenosine 3′,5′-monophosphate levels in the pancreatic B cell. Endocrinology 117:834–840, 1985
      OpenUrlCrossRefPubMedWeb of Science
    38. ↵
      Bjorklund A, Grill VE: Relief from glucose-induced over-stimulation sensitizes the adenylate cyclase-cAMP system of rat pancreatic islets. J Endocrinol 166:537–544, 2000
      OpenUrlAbstract
    39. ↵
      Henquin JC, Meissner HP: Dibutyryl cyclic AMP triggers Ca2+ influx and Ca2+-dependent electrical activity in pancreatic B cells. Biochem Biophys Res Commun 112:614–620, 1983
      OpenUrlCrossRefPubMed
    40. ↵
      Sanchez-Andres JV, Gomis A, Valdeolmillos M: The electrical activity of mouse pancreatic beta-cells recorded in vivo shows glucose-dependent oscillations. J Physiol (Lond) 486:223–228, 1995
      OpenUrlPubMedWeb of Science
    41. ↵
      Gomis A, Sanchez-Andres JV, Valdeolmillos M: Oscillatory patterns of electrical activity in mouse pancreatic islets of Langerhans recorded in vivo. Pflugers Arch 432:510–515, 1996
      OpenUrlCrossRefPubMedWeb of Science
    42. ↵
      Fernandez J, Valdeolmillos M: Synchronous glucose-dependent [Ca2+]i oscillations in mouse pancreatic islets of Langerhans recorded in vivo. FEBS Lett 477:33–36, 2000
      OpenUrlCrossRefPubMedWeb of Science
    43. ↵
      Jung SK, Aspinwall CA, Kennedy RT: Detection of multiple patterns of oscillatory oxygen consumption in single mouse islets of Langerhans. Biochem Biophys Res Commun 259:331–335, 1999
      OpenUrlCrossRefPubMedWeb of Science
    44. ↵
      Chou HF, Berman N, Ipp E: Oscillations of lactate released from islets of Langerhans: evidence for oscillatory glycolysis in beta-cells. Am J Physiol 262:E800–E805, 1992
      OpenUrlAbstract/FREE Full Text
    45. ↵
      McCormack JG, Denton RM: Role of calcium ions in the regulation of intramitochondrial metabolism: properties of the Ca2+-sensitive dehydrogenases within intact uncoupled mitochondria from the white and brown adipose tissue of the rat. Biochem J 190:95–105, 1980
      OpenUrlAbstract/FREE Full Text
    46. ↵
      Denton RM, McCormack JG: Ca2+ transport by mammalian mitochondria and its role in hormone action. Am J Physiol 249:E543–E554, 1985
      OpenUrlAbstract/FREE Full Text
    47. ↵
      Leech CA, Holz GG, Habener JF: Voltage-independent calcium channels mediate slow oscillations of cytosolic calcium that are glucose dependent in pancreatic beta-cells. Endocrinology 135:365–372, 1994
      OpenUrlCrossRefPubMed
    48. ↵
      Westerlund J, Hellman B, Bergsten P: Pulsatile insulin release from mouse islets occurs in the absence of stimulated entry of Ca2+. J Clin Invest 97:1860–1863, 1996
      OpenUrlCrossRefPubMedWeb of Science
    49. ↵
      Dryselius S, Lund PE, Gylfe E, Hellman B: Variations in ATP-sensitive K+ channel activity provide evidence for inherent metabolic oscillations in pancreatic beta-cells. Biochem Biophys Res Commun 205:880–885, 1994
      OpenUrlCrossRefPubMedWeb of Science
    50. ↵
      Hellman B, Gylfe E, Bergsten P, Grapengiesser E, Lund PE, Berts A, Dryselius S, Tengholm A, Liu YJ, Eberhardson M, Chow RH: The role of Ca2+ in the release of pancreatic islet hormones. Diabete Metab 20:123–131, 1994
      OpenUrlPubMedWeb of Science
    51. ↵
      Hellman B, Gylfe E, Grapengiesser E, Lund PE, Berts A: Cytoplasmic Ca2+ oscillations in pancreatic beta-cells. Biochim Biophys Acta 1113:295–305, 1992
      OpenUrlCrossRefPubMed
    52. ↵
      Pipeleers D, Kiekens R, Ling Z, Wilikens A, Schuit F: Physiologic relevance of heterogeneity in the pancreatic beta-cell population. Diabetologia 37 (Suppl. 2):S57–S64, 1994
      OpenUrl
    53. ↵
      Matschinsky FM: Banting Lecture 1995: A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes 45:223–241, 1996
      OpenUrlAbstract/FREE Full Text
    54. ↵
      Valdeolmillos M, Gomis A, Sanchez-Andres JV: In vivo synchronous membrane potential oscillations in mouse pancreatic beta-cells: lack of co-ordination between islets. J Physiol (Lond) 493:9–18, 1996
      OpenUrlPubMedWeb of Science
    55. ↵
      Pralong WF, Spat A, Wollheim CB: Dynamic pacing of cell metabolism by intracellular Ca2+ transients. J Biol Chem 269:27310–27314, 1994
      OpenUrlAbstract/FREE Full Text
    56. ↵
      Kennedy ED, Wollheim CB: Role of mitochondrial calcium in metabolism-secretion coupling in nutrient-stimulated insulin release. Diabete Metab 24:15–24, 1998
    57. ↵
      Civelek VN, Deeney JT, Kubik K, Schultz V, Tornheim K, Corkey BE: Temporal sequence of metabolic and ionic events in glucose-stimulated clonal pancreatic beta-cells (HIT). Biochem J 315:1015–1019, 1996
    58. ↵
      Atwater I, Rojas E, Scott A: Simultaneous measurements of insulin release and electrical activity from single microdissected mouse islets of Langerhans (Proceedings). J Physiol (Lond) 291:57P, 1979
      OpenUrlPubMed
    59. Barbosa RM, Silva AM, Tome AR, Stamford JA, Santos RM, Rosario LM: Real time electrochemical detection of 5-HT/insulin secretion from single pancreatic islets: effect of glucose and K+ depolarization. Biochem Biophys Res Commun 228:100–104, 1996
      OpenUrlCrossRefPubMedWeb of Science
    60. Barbosa RM, Silva AM, Tome AR, Stamford JA, Santos RM, Rosario LM: Control of pulsatile 5-HT/insulin secretion from single mouse pancreatic islets by intracellular calcium dynamics. J Physiol (Lond) 510:135–143, 1998
      OpenUrlCrossRefPubMedWeb of Science
    61. ↵
      Bergsten P, Hellman B: Glucose-induced cycles of insulin release can be resolved into distinct periods of secretory activity. Biochem Biophys Res Commun 192:1182–1188, 1993
      OpenUrlCrossRefPubMedWeb of Science
    62. ↵
      Eliasson L, Renstrom E, Ding WG, Proks P, Rorsman P: Rapid ATP-dependent priming of secretory granules precedes Ca2+-induced exocytosis in mouse pancreatic B-cells. J Physiol (Lond) 503:399–412, 1997
      OpenUrlCrossRefPubMedWeb of Science
    63. ↵
      Bergsten P, Hellman B: Glucose-induced amplitude regulation of pulsatile insulin secretion from individual pancreatic islets. Diabetes 42:670–674, 1993
      OpenUrlAbstract/FREE Full Text
    64. ↵
      Stagner JI, Samols E: Perturbation of insulin oscillations by nerve blockade in the in vitro canine pancreas. Am J Physiol 248:E516–E521, 1985
      OpenUrlAbstract/FREE Full Text
    65. Stagner JI, Samols E: Role of intrapancreatic ganglia in regulation of periodic insular secretions. Am J Physiol 248:E522–E530, 1985
      OpenUrlAbstract/FREE Full Text
    66. Sundsten T, Ortsäter H, Bergsten P: Inhibition of intrapancreatic ganglia causes sustained and non-oscillatory insulin release from perfused pancreas (Abstract). Diabetologia 41:76A, 1998
      OpenUrl
    67. ↵
      Bergsten P: Pathophysiology of impaired pulsatile insulin release. Diabete Metab Res Rev 16:179–191, 2000
      OpenUrlCrossRef
    68. ↵
      Stagner JI, Samols E, Weir GC: Sustained oscillations of insulin, glucagon, and somatostatin from the isolated canine pancreas during exposure to a constant glucose concentration. J Clin Invest 65:939–942, 1980
    69. ↵
      Ashcroft FM, Rorsman P: ATP-sensitive K+ channels: a link between B-cell metabolism and insulin secretion. Biochem Soc Trans 18:109–111, 1990
      OpenUrlFREE Full Text
    View Abstract
    PreviousNext
    Back to top

    In this Issue

    February 2002, 51(suppl 1)
    • Table of Contents
    • Index by Author
    Sign up to receive current issue alerts
    View Selected Citations (0)
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word about Diabetes.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Role of Oscillations in Membrane Potential, Cytoplasmic Ca2+, and Metabolism for Plasma Insulin Oscillations
    (Your Name) has forwarded a page to you from Diabetes
    (Your Name) thought you would like to see this page from the Diabetes web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Role of Oscillations in Membrane Potential, Cytoplasmic Ca2+, and Metabolism for Plasma Insulin Oscillations
    Peter Bergsten
    Diabetes Feb 2002, 51 (suppl 1) S171-S176; DOI: 10.2337/diabetes.51.2007.S171

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Add to Selected Citations
    Share

    Role of Oscillations in Membrane Potential, Cytoplasmic Ca2+, and Metabolism for Plasma Insulin Oscillations
    Peter Bergsten
    Diabetes Feb 2002, 51 (suppl 1) S171-S176; DOI: 10.2337/diabetes.51.2007.S171
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • IN VITRO OSCILLATIONS OF ISLET MEMBRANE POTENTIAL AND [Ca2+]i
      • IN VIVO OSCILLATIONS OF ISLET MEMBRANE POTENTIAL AND [Ca2+]i
      • IN VITRO OSCILLATIONS OF ISLET METABOLISM
      • IN VIVO OSCILLATIONS OF ISLET METABOLISM
      • MODEL OF IN VIVO OSCILLATORY MEMBRANE POTENTIAL, [Ca2+]i, pO2, AND INSULIN RELEASE
      • DISCUSSION OF THE MODEL
      • CONCLUSIONS
      • Acknowledgments
      • Footnotes
      • REFERENCES
    • Figures & Tables
    • Info & Metrics
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Control Mechanisms of the Oscillations of Insulin Secretion In Vitro and In Vivo
    • Metabolic Oscillations in β-Cells
    • Glucose-Stimulated Oscillations in Free Cytosolic ATP Concentration Imaged in Single Islet β-Cells
    Show more Section 4: Oscillations in β-Cells

    Similar Articles

    Navigate

    • Current Issue
    • Online Ahead of Print
    • Scientific Sessions Abstracts
    • Collections
    • Archives
    • Submit
    • Subscribe
    • Email Alerts
    • RSS Feeds

    More Information

    • About the Journal
    • Instructions for Authors
    • Journal Policies
    • Reprints and Permissions
    • Advertising
    • Privacy Policy: ADA Journals
    • Copyright Notice/Public Access Policy
    • Contact Us

    Other ADA Resources

    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • Scientific Sessions Abstracts
    • Standards of Medical Care in Diabetes
    • BMJ Open - Diabetes Research & Care
    • Professional Books
    • Diabetes Forecast

     

    • DiabetesJournals.org
    • Diabetes Core Update
    • ADA's DiabetesPro
    • ADA Member Directory
    • Diabetes.org

    © 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.